Bio View (BIOV) Ratios
Bio View Ratios
IL:BIOV's free cash flow for Q2 2026 was $154.50K. For the 2026 fiscal year, IL:BIOV's free cash flow was decreased by $-9.00K and operating cash flow was $163.50K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.88 | 2.51 | 2.68 | 3.11 | 3.43 |
| Quick Ratio | 1.17 | 1.65 | 2.15 | 2.59 | 2.88 |
| Cash Ratio | 0.57 | 0.84 | 1.32 | 1.97 | 2.30 |
| Solvency Ratio | -1.29 | -0.14 | 0.15 | 0.15 | 0.28 |
| Operating Cash Flow Ratio | -0.36 | -0.32 | 0.01 | 0.10 | 0.39 |
| Short-Term Operating Cash Flow Coverage | -2.36 | -1.96 | 0.10 | 0.77 | 3.00 |
| Net Current Asset Value | $ 5.68M | $ 13.90M | $ 17.28M | $ 17.10M | $ 15.87M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.06 | 0.08 | 0.10 | 0.12 |
| Debt-to-Equity Ratio | 0.30 | 0.09 | 0.13 | 0.14 | 0.17 |
| Debt-to-Capital Ratio | 0.23 | 0.08 | 0.11 | 0.13 | 0.15 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.11 | 1.47 | 1.54 | 1.48 | 1.47 |
| Debt Service Coverage Ratio | -8.74 | -0.63 | 1.28 | 1.48 | 2.88 |
| Interest Coverage Ratio | -33.63 | -7.71 | 1.86 | 3.79 | 10.24 |
| Debt to Market Cap | 0.06 | 0.04 | 0.03 | 0.00 | 0.00 |
| Interest Debt Per Share | 22.30 | 0.17 | 0.03 | 0.31 | 0.35 |
| Net Debt to EBITDA | 0.30 | 6.61 | -4.16 | -5.90 | -3.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.89% | 60.65% | 61.48% | 57.20% | 57.63% |
| EBIT Margin | -45.30% | -10.30% | 3.19% | 3.81% | 9.74% |
| EBITDA Margin | -36.06% | -3.68% | 8.42% | 8.94% | 14.57% |
| Operating Profit Margin | -39.15% | -11.21% | 2.20% | 3.95% | 9.67% |
| Pretax Profit Margin | -45.90% | -11.14% | 2.29% | 3.00% | 8.79% |
| Net Profit Margin | -76.93% | -12.27% | 1.10% | 2.01% | 7.16% |
| Continuous Operations Profit Margin | -76.93% | -12.27% | 1.10% | 2.01% | 7.16% |
| Net Income Per EBT | 167.62% | 110.19% | 48.06% | 67.09% | 81.40% |
| EBT Per EBIT | 117.22% | 99.34% | 104.05% | 76.02% | 90.95% |
| Return on Assets (ROA) | -77.10% | -9.36% | 0.91% | 1.40% | 5.46% |
| Return on Equity (ROE) | -162.85% | -13.72% | 1.40% | 2.08% | 8.04% |
| Return on Capital Employed (ROCE) | -69.14% | -12.08% | 2.55% | 3.59% | 9.32% |
| Return on Invested Capital (ROIC) | -62.01% | -10.66% | 1.11% | 2.23% | 7.10% |
| Return on Tangible Assets | -77.10% | -9.36% | 0.91% | 1.40% | 5.46% |
| Earnings Yield | -67.69% | -7.91% | 0.83% | 0.01% | 0.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.74 | 5.28 | 4.69 | 5.51 | 6.91 |
| Payables Turnover | 17.53 | 15.85 | 5.22 | 7.50 | 10.10 |
| Inventory Turnover | 1.84 | 1.21 | 2.12 | 2.40 | 2.81 |
| Fixed Asset Turnover | 6.13 | 10.25 | 8.43 | 5.69 | 5.70 |
| Asset Turnover | 1.00 | 0.76 | 0.83 | 0.70 | 0.76 |
| Working Capital Turnover Ratio | 1.79 | 1.47 | 1.70 | 1.41 | 1.61 |
| Cash Conversion Cycle | 224.62 | 347.95 | 179.71 | 169.65 | 146.59 |
| Days of Sales Outstanding | 47.18 | 69.16 | 77.77 | 66.19 | 52.85 |
| Days of Inventory Outstanding | 198.27 | 301.83 | 171.88 | 152.14 | 129.88 |
| Days of Payables Outstanding | 20.83 | 23.03 | 69.94 | 48.69 | 36.14 |
| Operating Cycle | 245.44 | 370.99 | 249.66 | 218.33 | 182.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -22.54 | -0.22 | 0.00 | 0.07 | 0.23 |
| Free Cash Flow Per Share | -22.93 | -0.22 | -0.00 | 0.04 | 0.19 |
| Dividend Paid and CapEx Coverage Ratio | -57.68 | -88.74 | 0.56 | 2.12 | 4.93 |
| Capital Expenditure Coverage Ratio | -57.68 | -88.74 | 0.56 | 2.12 | 4.93 |
| Operating Cash Flow Coverage Ratio | -1.09 | -1.57 | 0.04 | 0.24 | 0.70 |
| Operating Cash Flow to Sales Ratio | -0.15 | -0.12 | 0.00 | 0.03 | 0.11 |
| Free Cash Flow Yield | -13.73% | -7.90% | -0.26% | 0.01% | 0.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.52 | -12.64 | 119.87 | 8723.79 | 2091.92 |
| Price-to-Sales (P/S) Ratio | 1.14 | 1.55 | 1.32 | 175.70 | 149.73 |
| Price-to-Book (P/B) Ratio | 2.41 | 1.73 | 1.68 | 181.10 | 168.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.28 | -12.66 | -379.43 | 10021.26 | 1765.36 |
| Price-to-Operating Cash Flow Ratio | -7.41 | -12.81 | 300.07 | 5290.15 | 1407.07 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.01 | -1.27 | -126.89 | 12.55 |
| Enterprise Value Multiple | -2.86 | -35.57 | 11.53 | 1959.13 | 1024.09 |
| Enterprise Value | 20.52M | 33.54M | 33.73M | 5.11B | 4.55B |
| EV to EBITDA | -2.86 | -35.57 | 11.53 | 1959.13 | 1024.09 |
| EV to Sales | 1.03 | 1.31 | 0.97 | 175.18 | 149.25 |
| EV to Free Cash Flow | -6.60 | -10.68 | -278.74 | 9991.16 | 1759.72 |
| EV to Operating Cash Flow | -6.71 | -10.80 | 220.44 | 5274.26 | 1402.57 |
| Tangible Book Value Per Share | 69.42 | 1.64 | 0.20 | 2.03 | 1.94 |
| Shareholders’ Equity Per Share | 69.42 | 1.64 | 0.20 | 2.03 | 1.94 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.68 | -0.10 | 0.52 | 0.33 | 0.19 |
| Revenue Per Share | 146.94 | 1.83 | 0.26 | 2.10 | 2.18 |
| Net Income Per Share | -113.04 | -0.22 | 0.00 | 0.04 | 0.16 |
| Tax Burden | 1.68 | 1.10 | 0.48 | 0.67 | 0.81 |
| Interest Burden | 1.01 | 1.08 | 0.72 | 0.79 | 0.90 |
| Research & Development to Revenue | 0.21 | 0.26 | 0.24 | 0.17 | 0.17 |
| SG&A to Revenue | 0.62 | 0.16 | 0.22 | 0.11 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.20 | 1.09 | 0.19 | 1.11 | 1.21 |
Currency in ILS